Cargando…
A tour de force provides novel insights into CD19-CAR T cell resistance mechanisms
Sworder et al.(1) developed an integrated simultaneous tumor and effector profiling (STEP) approach to study resistance mechanisms to CD19-CAR T cell therapy in large B-cell lymphomas. Their study provides novel biological insights and paves the way for future interventions.
Autores principales: | Talleur, Aimee C., Gottschalk, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975327/ https://www.ncbi.nlm.nih.gov/pubmed/36812888 http://dx.doi.org/10.1016/j.xcrm.2023.100949 |
Ejemplares similares
-
CD70 CAR T cells in AML: Form follows function
por: Mirazee, Justin, et al.
Publicado: (2022) -
Factoring in the force: A novel role for eIF6
por: Wilson, Darren Graham Samuel, et al.
Publicado: (2022) -
Allogeneic CAR Cell Therapy—More Than a Pipe Dream
por: Caldwell, Kenneth J., et al.
Publicado: (2021) -
Hatched and starved: Two chromatin compaction mechanisms join forces to silence germ cell genome
por: Morao, Ana Karina, et al.
Publicado: (2021) -
Forcing contact inhibition of locomotion
por: Roycroft, Alice, et al.
Publicado: (2015)